A Study of DeTIL-0255 in Adults With Advanced Malignancies


Study Number
2058021
Phase
I
Age Group
Adult
Purpose

This is a first-in-human Phase 1 multicenter, open-label oncology study designed to evaluate the safety and efficacy of NX-DeTIL-0255-201 in patients with advanced malignancies.

Full Title

A Phase 1 Safety and Tolerability Study of DeTIL-0255 in Adults with Advanced Malignancies

ClinicalTrials.Gov ID
NCT05107739

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.